Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An "emission-computed tomography enhancer" is not a standard, well-defined molecular target or receptor. Instead, this term refers to agents, algorithms, or molecular probes that improve the quality, sensitivity, specificity, or resolution of emission computed tomography (ECT) imaging modalities such as SPECT (Single-Photon Emission Computed Tomography) and PET (Positron Emission Tomography). These enhancers can be radiotracers/radioligands, image reconstruction algorithms, or reporter genes/proteins.
Varies depending on the specific enhancer; examples include increasing target tissue uptake of radiotracers, improving radiotracer binding, and reducing image noise/artifacts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Emission-computed Tomography Enhancer.